Skip to Content
    Call Our 24/7 Helpline 800.272.3900

    Alzheimer’s Association Business Consortium (AABC)

    Alzheimer’s Association Business Consortium (AABC)

    The mission of the Alzheimer’s Association Business Consortium (AABC) is to advance Alzheimer’s disease and dementia research through innovation in small- and medium-size biotechnology, diagnostics, medical device and contract research organizations.

    AABC members work in areas of common interest pre-competitively to advance both the field of dementia research and the goals of its member organizations. They provide leadership and direction to the group’s areas of focus, which include, but are not limited to, collaborations, recognition and visibility, and knowledge and information sharing.


    Collaborations

    Collaborations are essential to companies as a way to share resources, expand infrastructure, save money and potentially create income. The consortium will provide a platform for companies looking for collaboration opportunities between member companies and enhance collaborations with large companies and other institutions external to the consortium.

    Recognition and visibility

    Companies will benefit from publications and positive publicity. As such, the AABC will look for ways to bring companies in this sector to the attention of the Alzheimer's Disease and Related Dementias community through publications, presentations and posters.

    Knowledge and information sharing

    The AABC will look for ways to share knowledge and information in a pre-competitive space. The group will share information about each member company. They may also share information on trusted consultants, CRO’s, ways to manage data in a small company, funding strategies and funding sources.

    Consortium members

    AI

    ADvantage Therapeutics
    Aribio
    Beacon Biosignals
    Bitfount
    BrainKey
    Clarity
    ForesightCares
    Icometrix
    Imeka
    Innovation Precision Health
    Kernel
    Mont4
    NeuraMetrix
    Neurotrack
    Neuroworx
    Novoic
    QMENTA
    Rancho Biosciences
    Unlearn.AI
    Together Senior Health
    Vistim Labs
    Wherible

    Diagnostics

    Alzeca Biosciences
    ASDERA
    Brain Spec
    CarThera
    CLAIRIgene
    Cogni.Dx
    Darmiyan
    Esya Labs
    Firalis Molecular Precision 
    Imaginostics
    InterVivo Solutions​
    Oasis Diagnostics
    Optina Diagnostics
    Perceiv AI
    Praana Tech
    RapidDx
    Sensify
    Septa Therapeutics
    TELL
    Telocyte

    Therapeutics

    712 North
    Acelot
    Alpha Cognition
    Asha
    Cenna Biosciences
    Cerecin
    Cognition Therapeutics
    Cognito Therapeutics
    Corvidane
    Cyclerion
    DiamiR
    EpicentRx
    ImmunoBrain Checkpoint
    INmune Bio Inc.
    Lauren Sciences
    LEXEO Therapeutics
    Manzanita Pharmaceuticals
    Mindr
    Mitochon Pharmaceuticals
    NeuroScios
    OptoCeutics
    Progenicyte Therapeutics
    Reservoir Neuro
    Treventis

    Other

    Bioexpert
    Clinical Enrollment
    Neuronascent
    Professional Case Management

    Meeting agendas and meeting minutes

    July 28, 2020 Agenda (PDF)
    Meeting minutes (PDF)
    July 15, 2019 Agenda (PDF)
    Meeting minutes (PDF)
    July 23, 2018 Agenda (PDF)
    Meeting minutes (PDF)
    February 15, 2018 Agenda (PDF)
    Meeting minutes (PDF)
    November 1, 2017 Agenda (PDF)
    Meeting minutes (PDF)
    February 1, 2017 Agenda (PDF)
    Meeting minutes (PDF)
    December 9, 2016 Meeting minutes (PDF)
    October 19, 2015 Agenda (PDF)
    Meeting minutes (PDF)
    August 25, 2015 Agenda (PDF)
    Meeting minutes (PDF)
    July 21, 2015 Agenda (PDF)
    Meeting minutes (PDF)
    Questionnaire results (PDF)
    May 13, 2015 Meeting minutes (PDF)
    March 2, 2015 Agenda (PDF)
    Meeting minutes (PDF)
    November 18, 2014 Agenda (PDF)
    Meeting minutes (PDF)

     

    AABC webinars

    AABC AAIC Meeting - July 2024 (VIDEO - please use passcode: 23%%FuH8)
    Federal Grant Funding - March 2023 (VIDEO - please use passcode: e@MgG0h%)
    Federal Grant Funding - March 2023 (PDF)
    Leveraging SBIR/STTR to Advance Alzheimer’s and Aging Innovations (VIDEO)
    Leveraging SBIR/STTR to Advance Alzheimer’s and Aging Innovations (PDF)
    Updates in Neuroimaging - December 2019 (PDF)
    Ask the Expert: CEO Panel - April 2019 (VIDEO)
    NIA-AA Research Framework: Towards a Biological Definition of Alzheimer’s Disease - November 2018 (PDF)
    Ask the Expert - August 2018 (PPT)
    IR and PR Strategy for Emerging Alzheimer's Companies - June 2018 (PDF)
    Ask The Expert - December 2017 (PDF)
    Ask The Expert - September 2017 (PPT)
    Ask The Expert - June 2017 (PPT)
    Ask The Expert - April 2017 (PPT)
    SBIR/STTR funding for Alzheimer's disease (PPT)
    What does pharma look for in evaluating companies as potential partners? (PDF)

    AABC / ISTAART webinars

    May 2018
    National Institute on Aging Small Business Award Program
     
    October 2017
    Biotech Innovation in New Therapeutic Approaches to Alzheimer's Disease

    May 2017
    Araclon ISTAART
    Cytox Intro
    DiamiR ISTAART
    NanoSomiX ISTAART

    Newsletters

    The AABC newsletter welcomes new members to the Alzheimer's Association Business Consortium, shares pre-competitive news about clinical developments and lists upcoming events of interest to Alzheimer's disease researchers and to biotechnology, diagnostics, medical device companies and other organizations developing Alzheimer's treatments.

    Quarter 4 2024 newsletter
    Quarter 2 2024 newsletter
    Quarter 1 2024 newsletter
    Quarter 4 2023 newsletter
    Quarter 3 2023 newsletter
    Quarter 1 2023 newsletter
    Quarter 3 2022 newsletter
    Quarter 1 2022 newsletter
    Quarter 3 2021 newsletter

    Quarter 2 2021 newsletter
    Quarter 1 2021 newsletter
    Quarter 4 2020 newsletter
    Quarter 3 2020 newsletter
    Quarter 4 2019 newsletter
    Quarter 3 2019 newsletter
    Quarter 2 2019 newsletter
    Quarter 1 2019 newsletter
    Quarter 1 and 2 2018 newsletter
    Quarter 3 2018 newsletter
    Quarter 3 2017 newsletter
    Quarter 2 2017 newsletter
    Quarter 4 2017 newsletter
    Quarter 3 2016 newsletter
    Quarter 2 2016 newsletter
    Quarter 4 2015 newsletter

    Publications

    Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank, Alzheimer’s Dementia: Translational Research & Clinical Interventions (TRCI) 

    Maximizing the Potential of Small Companies in Alzheimer’s Disease Research: Challenges and Opportunities (PPT)

    Events

    Past events:

    The AABC Translation Animal Models Group, chaired by Joseph Araujo, InterVivo Solutions, and facilitated by Rebecca Edelmayer, Alzheimer’s Association, in collaboration with MODEL-AD members held a think tank in Washington, D.C., Nov. 28-29, 2018. The think tank was a shoulder meeting to the Alzheimer’s Association Research Roundtable and was well attended. The agenda consisted of sessions addressing proteomics, genomics and metabolomics, modern behavioral models, and translational, experimental and operational issues. The think tank proceedings will be submitted for publication. View the guest logistics or agenda for more information.

    Get more information

    The AABC welcomes new members who are aligned in its commitment to research and innovation. To express interest in joining, email Ornit Chiba-Falek, chair; Theresa Devins, co-chair; or Christopher Weber, Ph.D., facilitator.

    For more information on the AABC, contact:

    Christopher Weber, Ph.D.
    Director, Global Science Initiatives
    Medical & Scientific Relations
    Alzheimer's Association
    cweber@alz.org

    The first survivor of Alzheimer's is out there, but we won't get there without you.

    Donate Now

    Don't just hope for a cure. Help us find one.

    Learn More

    Become a member of the only professional society for Alzheimer's and dementia science.

    Join ISTAART